PRESS RELEASEMÉRIGNAC, FRANCE – 20 MARCH 2025 EXOSENS JOINS THE SBF 120 INDEX Exosens (Ticker: EXENS – ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, announces that it will join the SBF 120 index, which groups the 120 largest companies in terms of liquidity and free-float market capitalization listed on the Euronext Paris stock exchange.
This will strengthen the visibility and liquidity profile of Exosens in the financial markets, while further supporting our attractiveness to investors, especially taking into account our leadership in mission-critical defense technologies”, said Jérôme Cerisier, Chief Executive Officer of Exosens.*** About Exosens Exosens is a high‐tech company with more than 85 years of experience in the innovation, development, manufacturing and sale of high‐end electro‐optical technologies in the field of amplification, detection and imaging.
"We are honored with the upcoming inclusion of Exosens into the SBF 120 index, which marks another important milestone for the Company less than one year after our successful IPO.
The story "EXOSENS JOINS THE SBF 120 INDEX" has 305 words across 9 sentences, which will take approximately 2 - 3 minutes for the average person to read.
Which news outlet covered this story?
The story "EXOSENS JOINS THE SBF 120 INDEX" was covered 21 hours ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 87 news stories per day.
It's most recent story was published 9 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
